Research is revealing a bad news, good news situation when it comes to how GLP-1 medications affect pregnancy. Sold under brand names such as Ozempic, prescriptions that mimic Glucagon-Like Peptide-1 are being used for blood sugar and weight control. Dominick Lemas, Ph.D. Women who used a GLP-1 within two…
A new study led by a University of Florida College of Medicine researcher has found that certain genetic variations of a receptor targeted by popular weight loss drugs are associated with a higher risk of obesity for children who were also exposed to gestational diabetes in the womb.
Ramzi Salloum, Ph.D., associate director for community outreach and engagement at the UF Health Cancer Institute, has been elected vice chair of the Florida Cancer Control and Research Advisory Council.
Faculty member Mei Liu, Ph.D., has co-authored two recent journal articles about COVID-19 in children. The articles were both published in April 2025 in the journals JAMA Network Open and PLOS Digital Health.
Jennifer LeLaurin, MPH, an assistant research scientist with the UF Institute for Child Health Policy and a Ph.D. candidate at HOBI, will give an oral presentation at the 15th Annual Dissemination and Implementation in Health Conference held in Washington, DC in December.
Matthew Gurka, Ph.D., served on the committee that organized the University of Florida’s inaugural Early Childhood National Summit held in Orlando earlier this year.
Hosted by the Institute for Child Health Policy Thursday, April 20, 3:30 to 6:30 p.m. Clinical and Translational Research Building (CTRB) Lobby Join child health researchers from across the University of Florida at the Institute for Child Health Policy’s annual research and…
